BIOCRYST SCHEDULED TO PRESENT AT WALL STREET FORUM

February 3, 2003
BIOCRYST SCHEDULED TO PRESENT AT WALL STREET FORUM Birmingham, Alabama - February 3, 2002 - BioCryst Pharmaceuticals, Inc. (Nasdaq NM: BCRX) Chairman and CEO, Charles E. Bugg, Ph.D., is scheduled to present at the Wall Street Analyst Forum on Monday, February 10, 2003, at 1:20 p.m. EST. The conference is being held at The Roosevelt Hotel in New York City. Interested investors can listen to the call live over the Internet during the conference at the following address:

http://events.onlinebroadcasting.com/fdfn/wsaf/021003/index.php .

What: BioCryst Pharmaceuticals, Inc. Presentation at the Wall Street Analyst Forum
When: Monday, February 10, 2003, 1:20 p.m., EST
Where: http://events.onlinebroadcasting.com/fdfn/wsaf/021003/index.php
How: Live over the Internet -- Simply log on to the web at the address above


Founded in 1986, BioCryst Pharmaceuticals, Inc. is a biopharmaceutical company focused on the design, optimization and development of small molecule pharmaceuticals to prevent, treat and control cancer, cardiovascular diseases and viral infections.

For those unable to listen at the designated time, the webcast will remain available for replay on http://events.onlinebroadcasting.com/fdfn/wsaf/021003/index.php for 30 days following the conference.